Ion AmpliSeq NGS allows for targeted sequencing for research workflows such as complete viral genome sequencing and variant detection for epidemiological studies of SARS-CoV-2 and the targeted species level resolution necessary for comprehensive and accurate relative abundance measurement of the microbiome.
The Ion AmpliSeq SARS-CoV-2 Research Panel consists of two pools with amplicons ranging from 125 bp to 275 bp in length and covers >99% of the SARS-CoV-2 genome, including all serotypes. The assay is part of a fast, automated, and accurate targeted NGS workflow that enables coronavirus typing in under a day.
The new Ion AmpliSeq Microbiome Health Research Kit allows for species-level resolution for metagenomic and biomarker research. Discover the impact of the microbiome on human health and disease.
New to next-generation sequencing? Learn the basics of NGS.